Sangamo Therapeutics Inc. buy Wedbush
Start price
11.08.23
/
50%
€0.99
Target price
11.08.24
€9.12
Performance (%)
-48.43%
Price
19:00
€0.51
Summary
This prediction is currently active. The BUY prediction by Wedbush for Sangamo Therapeutics Inc. is performing very badly with a performance of -48.43%. This prediction currently runs until 11.08.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sangamo Therapeutics Inc. | -9.686% | -9.686% |
| iShares Core DAX® | -0.683% | 1.890% |
| iShares Nasdaq 100 | 0.335% | 4.631% |
| iShares Nikkei 225® | -1.486% | -2.361% |
| iShares S&P 500 | -0.523% | 2.324% |
Comments by Wedbush for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Wedbush from $16.00 to $10.00. They now have an "outperform" rating on the stock.
Ratings data for SGMO provided by MarketBeat
Stopped prediction by Wedbush for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.97
27.02.23
27.02.23
€15.12
27.02.24
27.02.24
-63.50%
28.02.24
28.02.24
